A PHASE-II STUDY OF HIGH-DOSE CONTINUOUS INFUSION INTERLEUKIN-2 WITH LYMPHOKINE-ACTIVATED KILLER-CELLS IN PATIENTS WITH METASTATIC MELANOMA

被引:86
作者
DUTCHER, JP
GAYNOR, ER
BOLDT, DH
DOROSHOW, JH
BAR, MH
SZNOL, M
MIER, J
SPARANO, J
FISHER, RI
WEISS, G
MARGOLIN, K
ARONSON, FR
HAWKINS, M
ATKINS, M
机构
[1] MONTEFIORE MED CTR, ALBERT EINSTEIN CANC CTR, NCI, IL2LAK EXTRAMURAL WORKING GRP, BRONX, NY 10467 USA
[2] CITY HOPE CANC RES CTR, DUARTE, CA USA
[3] LOYOLA UNIV, MED CTR, MAYWOOD, IL 60153 USA
[4] UNIV TEXAS, HLTH SCI CTR, SAN ANTONIO, TX 78284 USA
[5] UNIV CALIF SAN FRANCISCO, SAN FRANCISCO, CA 94143 USA
[6] TUFTS UNIV, NEW ENGLAND MED CTR, BOSTON, MA 02111 USA
[7] NCI, BETHESDA, MD 20892 USA
关键词
D O I
10.1200/JCO.1991.9.4.641
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:641 / 648
页数:8
相关论文
共 29 条
[1]   METASTATIC MALIGNANT-MELANOMA TREATED WITH COMBINED BOLUS AND CONTINUOUS INFUSION INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS [J].
BAR, MH ;
SZNOL, M ;
ATKINS, MB ;
CIOBANU, N ;
MICETICH, KC ;
BOLDT, DH ;
MARGOLIN, KA ;
ARONSON, FR ;
RAYNER, AA ;
HAWKINS, MJ ;
MIER, JW ;
PAIETTA, E ;
FISHER, RI ;
WEISS, GR ;
DOROSHOW, JH .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (07) :1138-1147
[2]  
BOLDT DH, 1988, CANCER RES, V48, P4409
[3]   A PHASE-II STUDY OF INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS IN PATIENTS WITH METASTATIC MALIGNANT-MELANOMA [J].
DUTCHER, JP ;
CREEKMORE, S ;
WEISS, GR ;
MARGOLIN, K ;
MARKOWITZ, AB ;
ROPER, M ;
PARKINSON, D ;
CIOBANU, N ;
FISHER, RI ;
BOLDT, DH ;
DOROSHOW, JH ;
RAYNER, AA ;
HAWKINS, M ;
ATKINS, M .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (04) :477-485
[4]  
DUTCHER JP, 1989, P AN M AM SOC CLIN, V8, P282
[5]  
DUTCHER JP, 1989, APR P AM SOC APH
[6]   METASTATIC RENAL-CANCER TREATED WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS - A PHASE-II CLINICAL-TRIAL [J].
FISHER, RI ;
COLTMAN, CA ;
DOROSHOW, JH ;
RAYNER, AA ;
HAWKINS, MJ ;
MIER, JW ;
WIERNIK, P ;
MCMANNIS, JD ;
WEISS, GR ;
MARGOLIN, KA ;
GEMLO, BT ;
HOTH, DF ;
PARKINSON, DR ;
PAIETTA, E .
ANNALS OF INTERNAL MEDICINE, 1988, 108 (04) :518-523
[7]  
GAYNOR E, 1989, Proceedings of the American Association for Cancer Research Annual Meeting, V30, P239
[8]  
GOODMAN GE, 1988, P AN M AM SOC CLIN, V7, P252
[9]  
GUCALP R, 1989, P AN M AM SOC CLIN, V8, P190
[10]   INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELL THERAPY OF SOLID TUMORS - ANALYSIS OF TOXICITY AND MANAGEMENT GUIDELINES [J].
MARGOLIN, KA ;
RAYNER, AA ;
HAWKINS, MJ ;
ATKINS, MB ;
DUTCHER, JP ;
FISHER, RI ;
WEISS, GR ;
DOROSHOW, JH ;
JAFFE, HS ;
ROPER, M ;
PARKINSON, DR ;
WIERNIK, PH ;
CREEKMORE, SP ;
BOLDT, DH .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (04) :486-498